Danaher Corp

DHR: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|#SLOCK|gyLOCK|ZRBm@qk

Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term

Life science stocks like Danaher's have been under pressure since late 2022, but with profits expected to rebound in the high single digits in 2026 and potentially accelerate even further in 2027-30, we see growing momentum in the industry and firm's profit growth trajectory.

Sponsor Center